In Vivo Metabolic Profiling and Elimination Kinetics of Suzetrigine in Dromedary Camels: Implications for Doping Control in Camel Racing

RATIONALE: Suzetrigine (VX-548, Journavx), the first oral non-opioid selective NaV1.8 sodium channel blocker approved by the US FDA in January 2025 for acute pain management, was investigated for its in vivo metabolic fate and elimination profile in dromedary camels following oral administration. METHODS: Urine and plasma samples were collected over a defined postadministration period and analysed by liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS). The relative abundance of each metabolite was tracked across the sampling window to establish elimination kinetics. RESULTS: Three metabolites were identified and characterised: two phase I metabolites, M1 (O-demethylation of the methoxyphenyl group) and M2 (monohydroxylation of M1), were detected in urine, while only M1 was observed in plasma. A phase II sulfonate conjugate, M3, was identified exclusively in urine. Compared with the wider metabolite panel from the authors' previously published camel liver study, the in vivo profile was more restricted, reflecting the differences between in vitro biotransformation systems and living biological systems. CONCLUSION: These findings provide the first in vivo metabolic reference data for suzetrigine in camels and establish M1 as the primary candidate marker for routine antidoping screening in this species.

Authors

Institutions

Publication Details

Journal
Rapid Communications in Mass Spectrometry
Published
2026-11-13
DOI
https://doi.org/10.1002/rcm.70207
Primary Topic
Doping in Sports
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

In Vivo Metabolic Profiling and Elimination Kinetics of Suzetrigine in Dromedary Camels: Implications for Doping Control in Camel Racing

Zubair Perwad, Shino Ann Koshy, Moses Philip, Tajudheen Kunhamu Karatt et al.
5 links
Rapid Communications in Mass Spectrometry
Doping in Sports
article

In Vivo Metabolic Profiling and Elimination Kinetics of Suzetrigine in Dromedary Camels: Implications for Doping Control in Camel Racing

Zubair Perwad, Shino Ann Koshy, Moses Philip, Tajudheen Kunhamu Karatt, Abdul Khader Karakka Kal, Samir Meissir, Michael Benedict Subhahar, Meleparappil Muhammed Ajeebsanu, Fatma Graiban AlMheiri, Fatma Ibrahim Alhammadi
article en

Abstract

RATIONALE: Suzetrigine (VX-548, Journavx), the first oral non-opioid selective NaV1.8 sodium channel blocker approved by the US FDA in January 2025 for acute pain management, was investigated for its in vivo metabolic fate and elimination profile in dromedary camels following oral administration. METHODS: Urine and plasma samples were collected over a defined postadministration period and analysed by liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS). The relative abundance of each metabolite was tracked across the sampling window to establish elimination kinetics. RESULTS: Three metabolites were identified and characterised: two phase I metabolites, M1 (O-demethylation of the methoxyphenyl group) and M2 (monohydroxylation of M1), were detected in urine, while only M1 was observed in plasma. A phase II sulfonate conjugate, M3, was identified exclusively in urine. Compared with the wider metabolite panel from the authors' previously published camel liver study, the in vivo profile was more restricted, reflecting the differences between in vitro biotransformation systems and living biological systems. CONCLUSION: These findings provide the first in vivo metabolic reference data for suzetrigine in camels and establish M1 as the primary candidate marker for routine antidoping screening in this species.

Rapid Communications in Mass SpectrometryVol. 41(2)
Central Veterinary Research Laboratory (AE)
Good health and well-being
Doping in Sports
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon